BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 31247317)

  • 1. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
    Lavra ZM; Pereira de Santana D; Ré MI
    Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Method of Constructing a Drug-Polymer Temperature-Composition Phase Diagram Using Hot-Melt Extrusion.
    Tian Y; Jones DS; Donnelly C; Brannigan T; Li S; Andrews GP
    Mol Pharm; 2018 Apr; 15(4):1379-1391. PubMed ID: 29205040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
    Ousset A; Bassand C; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
    Pharm Dev Technol; 2019 Jun; 24(5):560-574. PubMed ID: 30303440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
    Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
    Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
    Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
    Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
    Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Synergetic Effects of Nonpolar and Polar Protic Solvents on the Properties of Felodipine and Soluplus in Solutions, Casting Films, and Spray-Dried Solid Dispersions.
    Chen Y; Huang W; Chen J; Wang H; Zhang S; Xiong S
    J Pharm Sci; 2018 Jun; 107(6):1615-1623. PubMed ID: 29454624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
    Bochmann ES; Neumann D; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.
    Dohrn S; Reimer P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Mol Pharm; 2020 Jul; 17(7):2721-2733. PubMed ID: 32463685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer/Amorphous Salt Solid Dispersions of Ciprofloxacin.
    Mesallati H; Tajber L
    Pharm Res; 2017 Nov; 34(11):2425-2439. PubMed ID: 28875408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
    Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.